KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Emergent BioSolutions (EBS) Exchange Rate Effect (2016 - 2025)

Emergent BioSolutions has reported Exchange Rate Effect over the past 15 years, most recently at -$200000.0 for Q3 2025.

For Q3 2025, Exchange Rate Effect changed N/A year-over-year to -$200000.0; the TTM value through Mar 2026 reached $800000.0, up 214.29%, while the annual FY2025 figure was $100000.0, N/A changed from the prior year.
Exchange Rate Effect for Q3 2025 was -$200000.0 at Emergent BioSolutions, down from $1.0 million in the prior quarter.
Over five years, Exchange Rate Effect peaked at $1.1 million in Q4 2022 and troughed at -$1.5 million in Q4 2023.
A 4-year average of -$64285.7 and a median of -$200000.0 in 2021 define the central range for Exchange Rate Effect.
Biggest five-year swings in Exchange Rate Effect: tumbled 400.0% in 2021 and later skyrocketed 250.0% in 2022.
Year by year, Exchange Rate Effect stood at -$200000.0 in 2021, then skyrocketed by 650.0% to $1.1 million in 2022, then tumbled by 236.36% to -$1.5 million in 2023, then soared by 86.67% to -$200000.0 in 2025.
Business Quant data shows Exchange Rate Effect for EBS at -$200000.0 in Q3 2025, $1.0 million in Q2 2025, and -$700000.0 in Q1 2025.